Personal record-keeping and educational reference. 18+. The app does not recommend substances, doses or treatment, or determine whether a substance is safe, approved or appropriate for you. Consult a qualified healthcare professional about decisions involving your health.
‹ Library

Hexarelin

Growth Hormone SecretagogueResearch Use Only

Also known as: Examorelin, HEX, His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2

The strongest of the GHRP family for GH release, but the quickest to lose effect with continuous use.

Dosing quick reference

research reference
Starting dose
100 mcg per injection
Frequency
1–3× daily
Typical range
100–200 mcg, 1–3× per day
Cycle
Keep cycles short (8–12 weeks) — the body adapts quickly
Receptor desensitization builds faster than other GHRPs; breaks matter.
Half-life
~55 minutes to ~1 hour
Route
Subcutaneous (research)
Common use
Studied as a potent growth-hormone secretagogue in growth-hormone axis research
Common vial sizes
2 mg · 5 mg
Storage
Lyophilized powder stored refrigerated or frozen away from light; reconstituted solution refrigerated (2–8 °C) and used within a few weeks
Stacking notes
Sometimes paired with a GHRH analog such as CJC-1295 No DAC in research protocols

Reported side effects

Transient prolactin or cortisol elevation cited in studiesWater retention reported anecdotallyInjection-site reactionPossible receptor desensitization with continued use cited in studies
Regulatory note: Not an approved therapeutic; sold for research purposes only
Calculate a dose →Hexarelin on The Peptide Guide →Deeper research reference: literature dose ranges, storage and handling, and where to source in Canada.

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.